Credit Suisse moves Celgene (Nasdaq: CELG) from Neutral to Outperform.
Needham & Company boosts Geron Corporation (Nasdaq: GERN) from Hold to Buy with a price target of $10. Click Here for more color.
Stifel Nicolaus raises ARIAD Pharmaceuticals (Nasdaq: ARIA) from Hold to Buy with a $7 price target.
KLR Group upgrades Goodrich Petroleum (NYSE: GDP) from Accumulate to Buy, while maintaining its price target at $26.
For daily real-time Upgrades go to http://www.streetinsider.com/Upgrades
BofA/Merrill Lynch cuts Quest Diagnostics (NYSE: DGX) from Buy to Underperform.
Morgan Stanley drops Home Properties (NYSE: HME) from Equalweight to Underweight.
Barclays slashes China Mobile (NYSE: CHL) from Overweight to Underweight.
Longbow Research lowers Old Dominion Freight Line (Nasdaq: ODFL) from Buy to Neutral and removed its $52 price target.
For daily real-time Downgrades go to http://www.streetinsider.com/downgrades
Zulily, Inc (Nasdaq: ZU) started by a handful today:
- BofA/Merrill Lynch at Neutral and $39 price target;
- William Blair at Outperform;
- Citi with a Neutral rating and price target of $38;
- RBC Capital with a Sector Perform and $40 price target; and
- Goldman Sachs at Neutral and $36 price target.
Credit Suisse initiates Allegion (NYSE: ALLE) at Outperform and price target of $48.
Morgan Stanley starts Relypsa, Inc. (Nasdaq: RLYP) with an Overweight rating and price target of $57.
For daily real-time New Coverage go to http://www.streetinsider.com/New+Coverage
Visit our new Ratings Insider portal to get the most comprehensive and up-to-date analyst coverage on the Street.